“Biogen has been a foundational presence in the Massachusetts life science ecosystem for close to half a century,” said Governor Maura Healey, in a statement. “We are thrilled to see them ...

As part of a bid to consolidate its footprint in Massachusetts, Biogen is foregoing its old home base to put down new roots in Cambridge. That said, the company won’t be moving far from its ...

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprint New building will be ...

Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty, which would consolidate the biotech giant's once-sprawling operations in ...

Biogen briefly moved its headquarters out to Weston, a town 30 minutes from Kendall Square, in 2010 before quickly announcing it would move back to Cambridge a year later.

The Ghana Black Stars thrashed Madagascar 3 -0 in the qualifiers for the 2026 FIFA World Cup. With huge international visibility, it is even more historic, and it can only buttress Ghana’s ...

The Black Stars continued their winning run in the 2026 World Cup qualifiers, beating Madagascar 3-0 on Monday, March 24, 2025, at the Mimoun Al Arsi Stadium in Morocco. A brace from Thomas Partey ...

Organon acquired regulatory and commercial rights in the United States for TOFIDENCE ™, a biosimilar to ACTEMRA ®, for intravenous infusion from Biogen. TOFIDENCE, the first approved ...

The Black Stars continued their winning run in the 2026 World Cup qualifiers, beating Madagascar 3-0 on Monday, March 24, 2025, at the Mimoun Al Arsi Stadium in Morocco. A brace from Thomas Partey ...

Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae. The $7.22-per-share deal for 89.8% of Sage is a 30 ...

Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...